STOCKHOLM (Reuters) – Swedish drug firm Meda said on Thursday it had agreed to buy Rottapharm for $3.1 billion in a deal that will boost its profitability and emerging market presence just weeks…

from Reuters: Deals http://ift.tt/1nMGeFa
via IFTTT

Publicités